Publication:
Identification of in vivo-expressed antigens of Staphylococcus aureus and their use in vaccinations for protection against nasal carriage

dc.contributor.authorSimon R. Clarkeen_US
dc.contributor.authorKirsten J. Brummellen_US
dc.contributor.authorMalcolm J. Horsburghen_US
dc.contributor.authorPhilip W. McDowellen_US
dc.contributor.authorSharifah A. Syed Mohamaden_US
dc.contributor.authorMelanie R. Stapletonen_US
dc.contributor.authorJorge Acevedoen_US
dc.contributor.authorRobert C. Readen_US
dc.contributor.authorNicholas P.J. Dayen_US
dc.contributor.authorSharon J. Peacocken_US
dc.contributor.authorJames J. Monden_US
dc.contributor.authorJohn F. Kokai-Kunen_US
dc.contributor.authorSimon J. Fosteren_US
dc.contributor.otherUniversity of Sheffielden_US
dc.contributor.otherBiosynexus Incorporateden_US
dc.contributor.otherMahidol Universityen_US
dc.contributor.otherUniversity of Liverpoolen_US
dc.date.accessioned2018-08-20T07:17:47Z
dc.date.available2018-08-20T07:17:47Z
dc.date.issued2006-04-15en_US
dc.description.abstractA spectrum of in vivo-expressed Staphylococcus aureus antigens was identified by probing bacteriophage expression libraries of S. aureus with serum samples from infected and uninfected individuals. Eleven recombinant antigenic proteins were produced, and specific antibody titers in a large collection of human serum samples were determined. Significantly increased concentrations of reactive immunoglobulin G (IgG) to 7 antigens were found in serum samples from ill individuals, compared with those in healthy individuals. Significantly higher concentrations of reactive IgG to 4 antigens, including iron-responsive surface determinant (Isd) A and IsdH, were found in serum samples from healthy individuals who were not nasal carriers of S. aureus, compared with those in healthy carriers. Vaccination of cotton rats with IsdA or IsdH protected against nasal carriage. Also, IsdA is involved in adherence of S. aureus to human desquamated nasal epithelial cells and is required for nasal colonization in the cotton rat model. Thus, vaccination with these antigens may prevent S. aureus carriage and reduce the prevalence of human disease. © 2006 by the Infectious Diseases Society of America. All rights reserved.en_US
dc.identifier.citationJournal of Infectious Diseases. Vol.193, No.8 (2006), 1098-1108en_US
dc.identifier.doi10.1086/501471en_US
dc.identifier.issn00221899en_US
dc.identifier.other2-s2.0-33645767174en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/23770
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=33645767174&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleIdentification of in vivo-expressed antigens of Staphylococcus aureus and their use in vaccinations for protection against nasal carriageen_US
dc.typeArticleen_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=33645767174&origin=inwarden_US

Files

Collections